Curcumin Nanocapsules Stabilized by Bovine Serum Albumin-capped Gold Nanoclusters (BSA-AuNCs) for Drug Delivery and Theranosis
Overview
Biotechnology
Authors
Affiliations
Nanotechnology plays an important role in the development of drug delivery, imaging, and diagnosis. In this study, nanocapsules containing protein-functionalized gold nanoclusters (AuNCs) as the shell and hydrophobic drug curcumin as the core were prepared as a tumor cell theranostic agent. After the nanocapsules were added into tumor cell media, they entered the cells with high efficiency and exhibited strong fluorescence within the cells. The results indicated that the nanocapsules were broken up in the cells and curcumin was released. Simultaneously, the nanocapsules exhibited significant inhibition effect against tumor cell proliferation in a concentration- and time-dependent manner, and the images of atomic force microscopy (AFM) showed that the cell morphology underwent obvious changes after the capsule treatment. Additionally, cell membrane appeared wrinkles after the cells treated with the nanocapsules, resulting in a rough cell surface, implying that the cytoskeleton would involve in the cell uptake of nanocapsules. Moreover, the AuNCs and curcumin in the system could exert synergistic effect on the inhibition of tumor cell growth and induction of cell apoptosis. The study highlights the potential of the system as a promising agent for drug delivery and tumor cell theranosis.
Chen K, Najer A, Charchar P, Saunders C, Thanapongpibul C, Klockner A Nat Commun. 2024; 15(1):10321.
PMID: 39609415 PMC: 11605077. DOI: 10.1038/s41467-024-53537-2.
Current Advances in Nanotechnology-Mediated Delivery of Herbal and Plant-Derived Medicines.
Jalili A, Bagherifar R, Nokhodchi A, Conway B, Javadzadeh Y Adv Pharm Bull. 2023; 13(4):712-722.
PMID: 38022806 PMC: 10676547. DOI: 10.34172/apb.2023.087.
Use of Albumin for Drug Delivery as a Diagnostic and Therapeutic Tool.
Karami E, Mesbahi Moghaddam M, Kazemi-Lomedasht F Curr Pharm Biotechnol. 2023; 25(6):676-693.
PMID: 37550918 DOI: 10.2174/1389201024666230807161200.
Iranshahy M, Hanafi-Bojd M, Aghili S, Iranshahi M, Nabavi S, Saberi S RSC Adv. 2023; 13(32):22250-22267.
PMID: 37492509 PMC: 10363773. DOI: 10.1039/d3ra02772d.
Guan R, Tao L, Hu Y, Zhang C, Wang Y, Hong M RSC Adv. 2022; 10(55):33299-33306.
PMID: 35515024 PMC: 9056666. DOI: 10.1039/d0ra05787h.